Manfred Ruediger, CEO of Ariceum Therapeutics | Talking Radiopharma Series

‘I’ve been doing this for a long, long time. I think it’s a very rewarding thing to do.’

 

This episode of the Venari Podcast’s Talking Radiopharma series saw Matthew Palmer speak to Ariceum Therapeutics CEO Manfred Ruediger. A serial biotech entrepreneur, Manfred has worked in executive functions in biotech for almost 25 years.

 

Ariceum’s development of novel targeted radiopharmaceuticals for cancer treatment – as well as Manfred’s considerable experience building out companies – certainly offered plenty of scope for discussion. Tune in to hear more about what Ariceum do differently, plus Manfred’s thoughts on team building and his advice for the radiopharmaceutical innovators of tomorrow!

Our thanks to the Ariceum CEO and his team for this fascinating podcast.